• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染严重程度监测:一项基于实验室诊断艰难梭菌的登记研究。

Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.

机构信息

NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.

出版信息

PLoS Med. 2012;9(7):e1001279. doi: 10.1371/journal.pmed.1001279. Epub 2012 Jul 31.

DOI:10.1371/journal.pmed.1001279
PMID:22859914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3409138/
Abstract

BACKGROUND

Changing clinical impact, as virulent clones replace less virulent ones, is a feature of many pathogenic bacterial species and can be difficult to detect. Consequently, innovative techniques monitoring infection severity are of potential clinical value.

METHODS AND FINDINGS

We studied 5,551 toxin-positive and 20,098 persistently toxin-negative patients tested for Clostridium difficile infection between February 1998 and July 2009 in a group of hospitals based in Oxford, UK, and investigated 28-day mortality and biomarkers of inflammation (blood neutrophil count, urea, and creatinine concentrations) collected at diagnosis using iterative sequential regression (ISR), a novel joinpoint-based regression technique suitable for serial monitoring of continuous or dichotomous outcomes. Among C. difficile toxin-positive patients in the Oxford hospitals, mean neutrophil counts on diagnosis increased from 2003, peaked in 2006-2007, and then declined; 28-day mortality increased from early 2006, peaked in late 2006-2007, and then declined. Molecular typing confirmed these changes were likely due to the ingress of the globally distributed severe C. difficile strain, ST1. We assessed the generalizability of ISR-based severity monitoring in three ways. First, we assessed and found strong (p<0.0001) associations between isolation of the ST1 severe strain and higher neutrophil counts at diagnosis in two unrelated large multi-centre studies, suggesting the technique described might be useful elsewhere. Second, we assessed and found similar trends in a second group of hospitals in Birmingham, UK, from which 5,399 cases were analysed. Third, we used simulation to assess the performance of this surveillance system given the ingress of future severe strains under a variety of assumptions. ISR-based severity monitoring allowed the detection of the severity change years earlier than mortality monitoring.

CONCLUSIONS

Automated electronic systems providing early warning of the changing severity of infectious conditions can be established using routinely collected laboratory hospital data. In the settings studied here these systems have higher performance than those monitoring mortality, at least in C. difficile infection. Such systems could have wider applicability for monitoring infections presenting in hospital.

摘要

背景

随着毒力更强的克隆体取代毒力较弱的克隆体,临床影响发生变化是许多病原细菌的特征,而且这种变化很难被检测到。因此,监测感染严重程度的创新技术具有潜在的临床价值。

方法和发现

我们研究了在英国牛津的一组医院中,1998 年 2 月至 2009 年 7 月间接受检测的 5551 例产毒素阳性和 20098 例持续产毒素阴性的艰难梭菌感染患者,使用迭代序列回归(ISR),一种适合连续或二分连续结果的新型基于连接点的回归技术,研究了诊断时的 28 天死亡率和炎症生物标志物(血液中性粒细胞计数、尿素和肌酐浓度)。在牛津医院的产毒素阳性艰难梭菌感染患者中,诊断时的中性粒细胞计数从 2003 年开始增加,在 2006-2007 年达到峰值,然后下降;28 天死亡率从 2006 年初开始上升,在 2006-2007 年末达到峰值,然后下降。分子分型证实这些变化可能是由于全球分布的严重艰难梭菌菌株 ST1 的传入。我们通过三种方式评估了基于 ISR 的严重程度监测的普遍性。首先,我们评估并发现,在两项独立的大型多中心研究中,ST1 严重菌株的分离与诊断时更高的中性粒细胞计数之间存在强烈的(p<0.0001)关联,这表明所描述的技术可能在其他地方有用。其次,我们评估并发现,在英国伯明翰的第二组医院中也存在类似的趋势,对其中的 5399 例病例进行了分析。第三,我们使用模拟来评估在各种假设下未来严重菌株传入时这种监测系统的性能。基于 ISR 的严重程度监测比死亡率监测更早地检测到感染严重程度的变化。

结论

使用常规收集的实验室医院数据,可以建立自动电子系统,为不断变化的传染病严重程度提供早期预警。在研究的环境中,这些系统在监测艰难梭菌感染方面的性能优于监测死亡率的系统。此类系统可更广泛地应用于监测住院感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/7aa4d2a475c5/pmed.1001279.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/fc15b8118648/pmed.1001279.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/3169690e92c4/pmed.1001279.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/f9f4efcfde23/pmed.1001279.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/b526f5c41e0f/pmed.1001279.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/be9d9c4ba300/pmed.1001279.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/a2cd396cb216/pmed.1001279.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/7aa4d2a475c5/pmed.1001279.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/fc15b8118648/pmed.1001279.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/3169690e92c4/pmed.1001279.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/f9f4efcfde23/pmed.1001279.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/b526f5c41e0f/pmed.1001279.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/be9d9c4ba300/pmed.1001279.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/a2cd396cb216/pmed.1001279.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a08/3409138/7aa4d2a475c5/pmed.1001279.g007.jpg

相似文献

1
Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.感染严重程度监测:一项基于实验室诊断艰难梭菌的登记研究。
PLoS Med. 2012;9(7):e1001279. doi: 10.1371/journal.pmed.1001279. Epub 2012 Jul 31.
2
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.艰难梭菌感染中细菌株型、宿主生物标志物与死亡率之间的关系。
Clin Infect Dis. 2013 Jun;56(11):1589-600. doi: 10.1093/cid/cit127. Epub 2013 Mar 5.
3
Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.在动物模型中,艰难梭菌(现为艰难梭状芽孢杆菌)的流行株比非流行株更具毒性。
BMC Microbiol. 2020 Feb 5;20(1):27. doi: 10.1186/s12866-020-1710-5.
4
Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.基于医院的艰难梭菌感染监测显示,2011 年至 2013 年期间,波兰不同地区的 PCR 核糖型 027 和 176 比例较高。
Euro Surveill. 2015;20(38). doi: 10.2807/1560-7917.ES.2015.20.38.30025.
5
Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study.由高毒力菌株引起的艰难梭菌感染:一项单中心真实世界研究。
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):99-107. doi: 10.1007/s10096-024-04982-w. Epub 2024 Nov 11.
6
Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).检测政策的变异性及其对艰难梭菌感染报告率的影响:欧洲艰难梭菌感染纵向诊断监测试点研究(LuCID)的结果
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1949-1956. doi: 10.1007/s10096-016-2746-1. Epub 2016 Sep 2.
7
Current status of Clostridium difficile infection epidemiology.艰难梭菌感染流行病学的现状。
Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S65-70. doi: 10.1093/cid/cis319.
8
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
9
Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.出现一种与暴发相关的、毒力增强的艰难梭菌变体。
J Clin Microbiol. 2015 Apr;53(4):1216-26. doi: 10.1128/JCM.03058-14. Epub 2015 Feb 4.
10
A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.艰难梭菌感染“干预”:毒素检测结果的改变导致艰难梭菌感染病例减少,而患者结局无变化。
Am J Infect Control. 2012 May;40(4):349-53. doi: 10.1016/j.ajic.2011.04.002. Epub 2011 Jul 27.

引用本文的文献

1
Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar.以社区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)流行率为例,检测感染监测中人群趋势的变化。
Am J Epidemiol. 2024 Dec 2;193(12):1848-1860. doi: 10.1093/aje/kwae091.
2
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.英国牛津郡 1998-2016 年时间趋势的大肠杆菌血流感染、尿路感染和抗生素敏感性:电子健康记录研究。
Lancet Infect Dis. 2018 Oct;18(10):1138-1149. doi: 10.1016/S1473-3099(18)30353-0. Epub 2018 Aug 17.
3

本文引用的文献

1
Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.大肠杆菌菌血症发病率的上升是由抗生素耐药分离株的增加所驱动的:牛津郡 1999-2011 年电子数据库研究。
J Antimicrob Chemother. 2012 Jun;67(6):1514-24. doi: 10.1093/jac/dks082. Epub 2012 Mar 21.
2
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.利用广泛的流行病学数据和分子分型技术对艰难梭菌医院病房传播进行特征描述。
PLoS Med. 2012 Feb;9(2):e1001172. doi: 10.1371/journal.pmed.1001172. Epub 2012 Feb 7.
3
Neonatal and maternal serum creatinine levels during the early postnatal period in preterm and term infants.
早产儿和足月新生儿生后早期的血清肌酐水平在新生儿期和产妇期。
PLoS One. 2018 May 24;13(5):e0196721. doi: 10.1371/journal.pone.0196721. eCollection 2018.
4
Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014.2006-2014 年中国香港成年人艰难梭菌感染的疾病负担。
Emerg Infect Dis. 2017 Oct;23(10):1671-1679. doi: 10.3201/eid2310.170797.
5
Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection.艰难梭菌感染期间黏膜免疫与肠道微生物群相互作用的系统建模
PLoS One. 2015 Jul 31;10(7):e0134849. doi: 10.1371/journal.pone.0134849. eCollection 2015.
Clostridium difficile mixed infection and reinfection.
艰难梭菌混合感染和再感染。
J Clin Microbiol. 2012 Jan;50(1):142-4. doi: 10.1128/JCM.05177-11. Epub 2011 Nov 9.
4
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.抗σ因子 TcdC 调节艰难梭菌 BI/NAP1/027 临床分离株的超强毒力。
PLoS Pathog. 2011 Oct;7(10):e1002317. doi: 10.1371/journal.ppat.1002317. Epub 2011 Oct 13.
5
Revisiting Mars and Venus: understanding gender differences in critical illness.重新审视火星和金星:理解危重病中的性别差异。
Crit Care. 2011 Aug 8;15(4):180. doi: 10.1186/cc10319.
6
Clinical Clostridium difficile: clonality and pathogenicity locus diversity.临床艰难梭菌:克隆性和毒力基因座多样性。
PLoS One. 2011;6(5):e19993. doi: 10.1371/journal.pone.0019993. Epub 2011 May 19.
7
Pathogen recognition by the innate immune system.先天免疫系统识别病原体。
Int Rev Immunol. 2011 Feb;30(1):16-34. doi: 10.3109/08830185.2010.529976.
8
Bacterial pathogen evolution: breaking news.细菌病原体进化:最新消息。
Trends Genet. 2011 Jan;27(1):32-40. doi: 10.1016/j.tig.2010.10.001. Epub 2010 Nov 1.
9
The role of toxin A and toxin B in Clostridium difficile infection.艰难梭菌感染中毒素 A 和毒素 B 的作用。
Nature. 2010 Oct 7;467(7316):711-3. doi: 10.1038/nature09397. Epub 2010 Sep 15.
10
High-throughput sequencing and clinical microbiology: progress, opportunities and challenges.高通量测序与临床微生物学:进展、机遇与挑战。
Curr Opin Microbiol. 2010 Oct;13(5):625-31. doi: 10.1016/j.mib.2010.08.003. Epub 2010 Sep 16.